News

Co-ordinating Editor, Paul Garner, discusses his experience of having COVID-19

CIDG Co-ordinating Editor, Paul Garner, outlines his experience of having COVID-19 in several recent news articles.

What's new! CIDG publications February 2022

During February 2022, we published one protocol and one new review in Issue 2, 2022 of the Cochrane Database of Systematic Reviews

CIDG end of year message 2021

The Cochrane Infectious Diseases Group (CIDG) editorial base in Liverpool thanks its readers, authors, referees, and editors for their support and contributions to the CIDG’s work throughout 2021. In this end of year newsletter, we reflect on the challenges and achievements of 2021 and plans for 2022.

Qualitative evidence: stopping research waste

What is it like as a youn

What's new! CIDG publications September 2021

During September 2021, we have published two new protocols and one updated review in Issue 9, 2021 of the

Updated Cochrane Review: Mass drug administration for malaria

Treating everyone for malaria: does it eliminate the disease?

What's new! CIDG publications July/August 2021

Impact of diagnostic strategies for tuberculosis using lateral flow ....

What was the aim of this review?

POC tests detecting HIV nucleic acids for diagnosis of HIV-1 or HIV-2 infection ...

Point‐of‐care tests for detecting HIV viral molecules in infants and children aged 18 months or lessWhy is improving the diagnosis of HIV infection important?

New Cochrane Review: Ivermectin for preventing and treating COVID-19

Ivermectin, a drug used to treat parasites such as scabies in humans and intestinal helminths in cattle, was screened in 2020 for activity against COV